Ontology highlight
ABSTRACT:
SUBMITTER: Andrei G
PROVIDER: S-EPMC3201796 | biostudies-literature | 2011 Oct
REPOSITORIES: biostudies-literature
Cell host & microbe 20111001 4
The HIV reverse-transcriptase inhibitor, tenofovir, was recently formulated into a vaginal gel for use as a microbicide. In human trials, a 1% tenofovir gel inhibited HIV sexual transmission by 39% and, surprisingly, herpes simplex virus-2 (HSV-2) transmission by 51%. We demonstrate that the concentration achieved intravaginally with a 1% tenofovir topical gel has direct antiherpetic activity. Tenofovir inhibits the replication of HSV clinical isolates in human embryonic fibroblasts, keratinocyt ...[more]